Allspring Global Investments Holdings LLC lowered its stake in Warrior Met Coal, Inc. (NYSE:HCC – Free Report) by 57.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 985 shares of the company’s stock after selling 1,328 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Warrior Met Coal were worth $63,000 as of its most recent filing with the SEC.
Several other large investors have also bought and sold shares of HCC. Dimensional Fund Advisors LP boosted its stake in shares of Warrior Met Coal by 2.5% during the second quarter. Dimensional Fund Advisors LP now owns 1,863,024 shares of the company’s stock valued at $116,937,000 after purchasing an additional 45,950 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Warrior Met Coal by 4.3% during the 2nd quarter. Renaissance Technologies LLC now owns 1,501,379 shares of the company’s stock worth $94,242,000 after acquiring an additional 62,200 shares during the period. American Century Companies Inc. grew its stake in shares of Warrior Met Coal by 6.1% during the 2nd quarter. American Century Companies Inc. now owns 1,440,965 shares of the company’s stock worth $90,449,000 after acquiring an additional 82,622 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Warrior Met Coal by 2.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,299,563 shares of the company’s stock worth $78,885,000 after purchasing an additional 30,053 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in Warrior Met Coal by 3.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 543,020 shares of the company’s stock worth $34,085,000 after purchasing an additional 16,574 shares during the period. 92.28% of the stock is owned by institutional investors and hedge funds.
Warrior Met Coal Stock Performance
NYSE:HCC opened at $65.56 on Tuesday. The firm has a market capitalization of $3.43 billion, a PE ratio of 9.06 and a beta of 1.02. The company has a debt-to-equity ratio of 0.09, a quick ratio of 5.37 and a current ratio of 5.81. Warrior Met Coal, Inc. has a 52-week low of $44.76 and a 52-week high of $75.53. The stock has a 50-day simple moving average of $59.65 and a two-hundred day simple moving average of $63.61.
Warrior Met Coal Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th will be issued a $0.08 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $0.32 dividend on an annualized basis and a yield of 0.49%. Warrior Met Coal’s dividend payout ratio is presently 4.42%.
Analyst Upgrades and Downgrades
HCC has been the topic of a number of research reports. Benchmark reissued a “hold” rating on shares of Warrior Met Coal in a report on Monday, August 5th. B. Riley lifted their price objective on Warrior Met Coal from $89.00 to $90.00 and gave the company a “buy” rating in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $75.75.
Read Our Latest Stock Analysis on Warrior Met Coal
Warrior Met Coal Profile
Warrior Met Coal, Inc produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production.
Featured Articles
- Five stocks we like better than Warrior Met Coal
- Most Volatile Stocks, What Investors Need to Know
- Intel: Is Now the Time to Be Brave?Â
- Airline Stocks – Top Airline Stocks to Buy Now
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Insider Trades May Not Tell You What You Think
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Warrior Met Coal Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Warrior Met Coal and related companies with MarketBeat.com's FREE daily email newsletter.